Novocure announced Monday morning that its electrical fields wearable device combined with chemotherapy passed a late-stage trial in pancreatic cancer, and the biotech now plans …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.